A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma

With the improved knowledge of disease biology and the introduction of immune checkpoints, there has been significant progress in treating renal cell carcinoma (RCC) patients. Individual treatment will differ according to risk stratification.